Stock-Based Compensation (Tables)
|
6 Months Ended |
Oct. 31, 2024 |
| Share-Based Payment Arrangement [Abstract] |
|
| Summary of Stock Option Activity |
A summary of the Company’s option activity during the six months ended October 31, 2024 is as follows: | | | | | | | | | | | | | | | | | | | | | | | | | Options Outstanding | | Number of Stock Options Outstanding | | Weighted Average Exercise Price | | Weighted Average Remaining Contractual Life (years) | | Aggregate Intrinsic Value | | (in thousands) | | | | | | (in thousands) | | Balance as of April 30, 2024 | 31,328 | | | $ | 13.97 | | | 5.68 | | $ | 268,167 | | | Options granted | 1,187 | | | 23.43 | | | | | | | Options exercised | (1,064) | | | 25.82 | | | | | | | Options cancelled | (513) | | | 19.77 | | | | | | | Balance as of October 31, 2024 | 30,938 | | | $ | 14.56 | | | 5.41 | | $ | 311,547 | | | Vested and exercisable as of October 31, 2024 | 24,887 | | | $ | 11.30 | | | 4.89 | | $ | 331,739 | | | Vested and expected to vest as of October 31, 2024 | 30,938 | | | $ | 14.56 | | | 5.41 | | $ | 311,547 | |
|
| Schedule of Valuation Assumptions |
The weighted average assumptions underlying the fair value estimation are provided in the following table: | | | | | | | | | | | | | | | | | Six Months Ended October 31, | | | 2024 | | 2023 | | Valuation assumptions: | | | | | | Expected dividend yield | | — | % | | — | % | | Expected volatility | | 66.2 | % | | 62.3 | % | | Expected term (years) | | 6.1 | | 6.5 | | Risk-free interest rate | | 3.6 | % | | 4.7 | % |
|
| Schedule of Restricted Stock Unit Activity |
A summary of the Company’s RSU activity during the six months ended October 31, 2024 is as follows: | | | | | | | | | | | | | RSUs Outstanding | | Number of RSUs | | Weighted Average Grant Date Fair Value Per Share | | (in thousands) | | | | Unvested Balance as of April 30, 2024 | 19,283 | | | $ | 24.26 | | | RSUs granted | 7,569 | | | 27.21 | | | RSUs vested | (3,858) | | | 26.50 | | | RSUs forfeited | (2,515) | | | 27.35 | | | Unvested Balance as of October 31, 2024 | 20,479 | | | $ | 25.11 | |
|
| Schedule of Fair Value of Shares to be Granted |
The following assumptions were used to calculate the fair value of shares to be granted under the 2020 ESPP during the period: | | | | | | | | | | | | | Six Months Ended October 31, | | 2024 | | 2023 | | Valuation assumptions: | | | | | Expected dividend yield | — | % | | — | % | | Expected volatility | 56.2 - 75.3% | | 64.0 - 70.1% | | Expected term (years) | 0.5 - 2.0 | | 0.5 - 2.0 | | Risk-free interest rate | 3.6 - 4.6% | | 5.0 - 5.5% |
|
| Summary of Effects of Stock-Based Compensation |
The following table summarizes the effects of stock-based compensation on the Company’s condensed consolidated statements of operations (in thousands): | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended October 31, | | Six Months Ended October 31, | | 2024 | | 2023 | | 2024 | | 2023 | | Cost of subscription | $ | 7,827 | | | $ | 8,514 | | | $ | 15,521 | | | $ | 16,570 | | | Cost of professional services | 484 | | | 479 | | | 1,198 | | | 939 | | | Sales and marketing | 20,802 | | | 18,226 | | | 39,635 | | | 35,005 | | | Research and development | 17,999 | | | 16,685 | | | 36,430 | | | 33,718 | | | General and administrative | 9,926 | | | 9,265 | | | 18,937 | | | 17,817 | | | Total stock-based compensation expense | $ | 57,038 | | | $ | 53,169 | | | $ | 111,721 | | | $ | 104,049 | |
|